ARQ Wealth Advisors LLC Takes Position in VanEck Pharmaceutical ETF $PPH

Posted by Brian Himes on Jul 12th, 2026

ARQ Wealth Advisors LLC acquired a new stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) in the first quarter, HoldingsChannel reports. The institutional investor acquired 9,030 shares of the company’s stock, valued at approximately $938,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in PPH. Fifth Third Bancorp bought a new stake in VanEck Pharmaceutical ETF during the 1st quarter worth approximately $120,000. Cherry Creek Investment Advisors Inc. increased its stake in shares of VanEck Pharmaceutical ETF by 5.3% in the first quarter. Cherry Creek Investment Advisors Inc. now owns 13,824 shares of the company’s stock worth $1,436,000 after purchasing an additional 695 shares in the last quarter. Kestra Advisory Services LLC increased its stake in shares of VanEck Pharmaceutical ETF by 126.8% in the first quarter. Kestra Advisory Services LLC now owns 4,873 shares of the company’s stock worth $506,000 after purchasing an additional 2,724 shares in the last quarter. Value Investment Professionals LLC bought a new stake in shares of VanEck Pharmaceutical ETF during the 1st quarter valued at $343,000. Finally, Turtle Creek Wealth Advisors LLC purchased a new position in shares of VanEck Pharmaceutical ETF during the 1st quarter valued at $208,000.

VanEck Pharmaceutical ETF Trading Down 0.8%

VanEck Pharmaceutical ETF stock traded down $0.83 during mid-day trading on Friday, hitting $108.80. The stock had a trading volume of 263,696 shares, compared to its average volume of 335,102. VanEck Pharmaceutical ETF has a one year low of $81.74 and a one year high of $112.58. The firm has a market capitalization of $950.91 million, a P/E ratio of 20.21 and a beta of 0.46. The firm’s 50 day moving average is $105.00 and its 200 day moving average is $105.28.

VanEck Pharmaceutical ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, July 7th. Stockholders of record on Wednesday, July 1st were paid a $0.6248 dividend. The ex-dividend date of this dividend was Wednesday, July 1st. This represents a $2.50 dividend on an annualized basis and a dividend yield of 2.3%.

VanEck Pharmaceutical ETF Profile

(Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.